- Home
- / EG
EG
Revenue
€262.3 M
FY, 2024
EG Summary
Company Summary
- Overview
- EG (Eurogenerics) is a pharmaceutical company that specializes in generic medicine. Its offerings include prescription medication, dietary supplements, medical devices, biosimilar medicines, etc.
- Type
- Subsidiary
- Status
- Active
- Founded
- 1979
- HQ
- Bruxelles, BE | view all locations
- Website
- https://www.eg.be/nl
- Cybersecurity rating
Table of Contents
Key People
Ann Osselaere, Pharmaceutical Affairs Director
Sophie Dewulf, Culture & People Director BE
Esther Melkebeke, BU Director Consumer Health Care
LocationsView all
1 location detected
Bruxelles, Bruxelles HQ
Belgium
Esplanade 1
EG Financials
Summary Financials
- Revenue (FY, 2024)
- €262.3M
- Gross profit (FY, 2024)
- €81.2M
- Net income (FY, 2024)
- €31.8M
- Cash (FY, 2024)
- €57.4M
- EBIT (FY, 2024)
- €41.6M